MOREHOUSE CCRE DP2- P47PHOX GENETIC POLYMORPHISMS IN CARDIOVASCULAR DISEASE
MOREHOUSE CCRE DP2- P47PHOX 心血管疾病中的基因多态性
基本信息
- 批准号:7724678
- 负责人:
- 金额:$ 20.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAtherosclerosisBiological MarkersBlood VesselsCardiovascular DiseasesCellsComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentEnzymesFundingGene ExpressionGenesGenetic PolymorphismGenetic VariationGenotypeGrantHomeostasisHydrogen PeroxideHypertensionHypertrophyInflammationInstitutionLinkage Disequilibrium MappingMapsMeasuresMentorsMolecularNAD(P)H oxidaseNADPH OxidaseObesityOxidative StressPathogenesisPatientsPopulationProteinsReactive Oxygen SpeciesResearchResearch PersonnelResourcesRoleSamplingSmooth Muscle MyocytesSourceSuperoxidesTrainingUnited States National Institutes of HealthVascular Diseasesbasecareercell growthcohortdensityexpectationgenetic associationgenetic variantinsightmigrationnovelpromoter
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
There is accumulating evidence that oxidative stress has a critical role in the pathogenesis of vascular disease. Reactive oxygen species (ROS) such as superoxide (02-) and hydrogen peroxide (H202) have profound effects on vascular smooth muscle cell (VSMC) growth and migration, endothelial function and inflammation. An imbalance in ROS homeostasis is associated with atherosclerosis, hypertension, and obesity. NAD(P)H oxidase is an enzyme that is the major source of 02- in vascular cells and absolutely required for VSMC growth and hypertrophy. This proposal is centered on p47phox, a key regulatory subunit of NAD(P)H oxidase. Currently there is relatively little information concerning the impact of p47phox genetic variations on its gene expression and development of cardiovascular disease. To address this issue, we hypothesize that there are novel genetic variants of p47phox gene that may influence its gene expression or protein activity and predispose to development of cardiovascular disease. Accordingly, we propose the following specific aims: 1) establish a high-density genetic variant map and linkage disequilibrium map on the p47phox gene locus; 2) characterize the functional impact of p47phox genetic variants on NADPH oxidase activity as measured in an set of immortalized lymphoblatoid cells from a cohort of patients with vascular disease as well classical analysis of p47phox promoter study; and 3) perform a genetic association study of the p47phox genotype with quantitative biomarkers of oxidative stress and vascular function in a bi-racial population-based sample of subjects that is accessible as part of our collaborative team. We anticipate that this project will provide important new insights into the molecular determinants of ROS homeostasis. It is our expectation that this developmental project will provide an excellent training and career opportunity for the PI under the guidance of a strong mentoring and collaborating team.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
越来越多的证据表明,氧化应激在血管疾病的发病机制中具有关键作用。活性氧(ROS)如超氧化物(O2-)和过氧化氢(H2 O2)对血管平滑肌细胞(VSMC)的生长和迁移、内皮功能和炎症具有深远的影响。ROS体内平衡的失衡与动脉粥样硬化、高血压和肥胖有关。NAD(P)H氧化酶是血管细胞中02-的主要来源并且是VSMC生长和肥大绝对需要的酶。这一建议是集中在p47 phox,一个关键的调节亚基的NAD(P)H氧化酶。目前,关于p47 phox基因变异对其基因表达和心血管疾病发展的影响的信息相对较少。为了解决这个问题,我们假设有新的遗传变异的p47 phox基因,可能会影响其基因表达或蛋白质活性,并容易发展为心血管疾病。因此,我们提出了以下具体目标:1)建立p47 phox基因位点的高密度遗传变异图谱和连锁不平衡图谱; 2)在来自血管疾病患者队列的一组永生化淋巴母细胞中测量p47 phox基因变异对NADPH氧化酶活性的功能影响以及p47 phox启动子研究的经典分析;和3)在作为我们的合作团队的一部分可获得的基于两种族人群的受试者样本中进行p47 phox基因型与氧化应激和血管功能的定量生物标志物的遗传关联研究。我们预计,该项目将提供重要的新的见解的ROS稳态的分子决定因素。我们期望这个发展项目将在强大的指导和合作团队的指导下为PI提供极好的培训和职业机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gary H Gibbons其他文献
Gary H Gibbons的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gary H Gibbons', 18)}}的其他基金
Morehouse Cardiovascular Research Center of Excellence
莫尔豪斯心血管卓越研究中心
- 批准号:
8082090 - 财政年份:2011
- 资助金额:
$ 20.85万 - 项目类别:
"Vasculata 2011" Conference grant application
“Vasculata 2011”会议资助申请
- 批准号:
8205558 - 财政年份:2011
- 资助金额:
$ 20.85万 - 项目类别:
Vascular Epigenome Dynamics in African-American Hypertensives
非裔美国人高血压的血管表观基因组动力学
- 批准号:
7727216 - 财政年份:2009
- 资助金额:
$ 20.85万 - 项目类别:
Vascular Epigenome Dynamics in African-American Hypertensives
非裔美国人高血压的血管表观基因组动力学
- 批准号:
8105517 - 财政年份:2009
- 资助金额:
$ 20.85万 - 项目类别:
Vascular Epigenome Dynamics in African-American Hypertensives
非裔美国人高血压的血管表观基因组动力学
- 批准号:
7922762 - 财政年份:2009
- 资助金额:
$ 20.85万 - 项目类别:
MOREHOUSE CCRE DP1- ENDOTHELIAL FUNCTION IN OBESE AFRICAN AMERICAN WOMEN
MOREHOUSE CCRE DP1 - 肥胖非洲裔美国女性的内皮功能
- 批准号:
7961305 - 财政年份:2008
- 资助金额:
$ 20.85万 - 项目类别:
MOREHOUSE CCRE DP1- ENDOTHELIAL FUNCTION IN OBESE AFRICAN AMERICAN WOMEN
MOREHOUSE CCRE DP1 - 肥胖非洲裔美国女性的内皮功能
- 批准号:
7724677 - 财政年份:2008
- 资助金额:
$ 20.85万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 20.85万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 20.85万 - 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 20.85万 - 项目类别:
Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 20.85万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 20.85万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 20.85万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 20.85万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 20.85万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
- 批准号:
10974007 - 财政年份:2023
- 资助金额:
$ 20.85万 - 项目类别:














{{item.name}}会员




